VivoSeq
Oncology

Hematopoietic and Lymphatic System Neoplasm

6

Pipeline Programs↗

13

Active Trials↗

5

Companies Involved↗

Hematopoietic and Lymphatic System Neoplasm is an early-stage landscape with 6 programs across 5 companies. The most active players are Incyte, Teva, Alnylam Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

30/100

Mech. Concentration

33/100

Completion Rate

50/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Incyte logo

Incyte

1 program

Phase 1Teva logo

Teva

1 program

Phase 2Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

1 program

Phase 2E

Eastern Cooperative Oncology Group

1 program

Phase 2T

Theodore Brasky PhD

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

15

clinical trials

Recruiting10 · 67%
Not yet recruiting3 · 20%
Suspended1 · 7%
Completed1 · 7%

Clinical Trials

Trial Activity

15 trials

Quality of End-of-Life Care for Children With Cancer: A COG Groupwide Observational Study
Recruiting·Children's Oncology Group·N/A·NCT07412002·2,425 enrolled
Biomarker-Guided Feasibility/Efficacy Trial of Ruxolitinib in Patients With High-Risk of Chronic Graft-Versus-Host Disease Development After Allogeneic Hematopoietic Cell Transplantation
Recruiting·CCity of Hope Medical Center·Phase 1·NCT07025538·42 enrolled
Impact of Physician Behavior on Cancer Distress
Recruiting·MMayo Clinic·N/A·NCT07325006·5,000 enrolled
A Pilot Study Exploring Four Types of Meditation Practices for Relaxation Among Cancer Survivors
Recruiting·CCity of Hope Medical Center·Preclinical·NCT06500377·44 enrolled
Symptom Management in the Bone Marrow Transplant Patient Population Using Virtual Reality
Recruiting·RRoswell Park Cancer Institute·Preclinical·NCT06798701·28 enrolled
A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome
Recruiting·OOHSU Knight Cancer Institute·Phase 2·NCT06895473·26 enrolled
Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Recruiting·NRG Oncology·Preclinical·NCT06279013·600 enrolled
A Pilot Study of Mindfulness-Based Stress Reduction (MBSR) in Patients With Cancer Experiencing Stress Who Live in Underserved and Rural Regions of Minnesota
Recruiting·MMayo Clinic·Preclinical·NCT07291011·45 enrolled
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Recruiting·MMayo Clinic·N/A·NCT06640010·30 enrolled
Piloting a Virtual Reality-Based, Randomized Controlled Trial of Psychosocial Responses to Neighborhood Physical Disorder
Recruiting·OOhio State University Comprehensive Cancer Center·Preclinical·NCT07216534·32 enrolled
Pilot Study to Evaluate the Feasibility of High Fiber Program in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Not yet recruiting·CCity of Hope Medical Center·Preclinical·NCT07664670·44 enrolled
Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids
Not yet recruiting·RRoswell Park Cancer Institute·Phase 2·NCT06827054·20 enrolled
Piloting a Novel Therapeutic for Sleep Disturbance in Palliative Care Over 5 Weeks: The PILLOW Study
Not yet recruiting·—·Preclinical·NCT07658677·50 enrolled
A Pilot Study of Self-Administered Acupressure for Fatigue Among Adolescent and Young Adult (AYA) Cancer Survivors
Completed·UUniversity of Michigan Rogel Cancer Center·Preclinical·NCT06442891·42 enrolled
Assessing the Feasibility of Aromatherapy Essential Oil Associated Changes on Nausea in Patients Receiving Infusion in the Ambulatory Setting
Suspended·CCity of Hope Medical Center·Preclinical·NCT07126301·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)